A. Caldara

579 total citations
26 papers, 309 citations indexed

About

A. Caldara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A. Caldara has authored 26 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in A. Caldara's work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Treatments and Mutations (5 papers). A. Caldara is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Treatments and Mutations (5 papers). A. Caldara collaborates with scholars based in Italy, United Kingdom and Denmark. A. Caldara's co-authors include Teodoro Sava, Antonella Ferro, Enzo Galligioni, Orazio Caffo, Michele Pavarana, A. Auriemma, Elena Fiorio, Anna Mercanti, Monica Giovannini and Rebecca Pedersini and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

A. Caldara

22 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Caldara Italy	9	172	124	100	71	70	26	309
Petroula Arapantoni-Dadioti Greece	12	158 0.9×	54 0.4×	131 1.3×	79 1.1×	47 0.7×	20	344
Laura Faivre France	9	181 1.1×	158 1.3×	56 0.6×	57 0.8×	31 0.4×	16	307
Chukwuemeka Ikpeazu United States	9	189 1.1×	144 1.2×	65 0.7×	42 0.6×	44 0.6×	23	356
Prabhsimranjot Singh United States	8	117 0.7×	141 1.1×	45 0.5×	50 0.7×	21 0.3×	26	325
G.K.H. Au China	11	293 1.7×	167 1.3×	57 0.6×	225 3.2×	308 4.4×	22	581
Tosol Yu South Korea	9	137 0.8×	99 0.8×	56 0.6×	67 0.9×	68 1.0×	21	326
Salma Alam United Kingdom	10	143 0.8×	160 1.3×	86 0.9×	53 0.7×	13 0.2×	14	332
Chaitali Nangia United States	9	197 1.1×	158 1.3×	43 0.4×	55 0.8×	45 0.6×	34	330
Seiichi Fukuyama Japan	12	190 1.1×	186 1.5×	65 0.7×	70 1.0×	10 0.1×	26	422
Joaquin Garcia United States	6	280 1.6×	126 1.0×	60 0.6×	231 3.3×	70 1.0×	9	450

Countries citing papers authored by A. Caldara

Since Specialization

Citations

This map shows the geographic impact of A. Caldara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Caldara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Caldara more than expected).

Fields of papers citing papers by A. Caldara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Caldara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Caldara. The network helps show where A. Caldara may publish in the future.

Co-authorship network of co-authors of A. Caldara

This figure shows the co-authorship network connecting the top 25 collaborators of A. Caldara. A scholar is included among the top collaborators of A. Caldara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Caldara. A. Caldara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferro, Antonella, Michela Campora, A. Caldara, et al.. (2024). Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 13(12). 3611–3611. 8 indexed citations

Rose, Fiorenza De, Lucia Di Brina, L. Menegotti, et al.. (2023). Whole Breast Irradiation Versus Intraoperative Electron Radiation Therapy for Breast Conserving Therapy: A Large Mature Single Institution Matched-Pair Evaluation of True Local Relapse, Progression Free Survival, and Overall Survival. International Journal of Radiation Oncology*Biology*Physics. 116(4). 757–769. 3 indexed citations

Ferro, Antonella, Daniele Generali, Orazio Caffo, et al.. (2023). Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?. Seminars in Oncology. 50(3-5). 90–101. 6 indexed citations

Dionisi, Francesco, Stefania Croci, Irene Giacomelli, et al.. (2019). Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma. Acta Oncologica. 58(9). 1238–1245. 34 indexed citations

Murgia, Viviana, Antonello Veccia, S. Brugnara, et al.. (2017). Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer. Anti-Cancer Drugs. 28(6). 654–659. 1 indexed citations

Bossi, Paolo, Rosalba Miceli, Laura D. Locati, et al.. (2017). A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Annals of Oncology. 28(11). 2820–2826. 54 indexed citations

Bossi, Paolo, Lital Hollander, Rosalba Miceli, et al.. (2017). First line cetuximab and cisplatin with or without paclitaxel in recurrent/metastatic head and neck cancer: A randomized phase IIb trial. Annals of Oncology. 28. v629–v629. 2 indexed citations

Murgia, Viviana, Orazio Caffo, A. Caldara, et al.. (2015). Concurrent chemoradiotherapy (cCTRT) with weekly cisplatin (wCDDP) in locally advanced cervical cancer (LACC) patients (pts): a monoinstitutional experience. Annals of Oncology. 26. vi35–vi35.

Caffo, Orazio, Viviana Murgia, Antonello Veccia, et al.. (2014). Weekly paclitaxel (wPCT) for pretreated patients (pts) with advanced non-small cell lung cancer (aNSCLC): Updated data from a single institution experience in the daily clinical practice.. Journal of Clinical Oncology. 32(15_suppl). e19143–e19143.

10.

Caffo, Orazio, Giovanni Pappagallo, S. Brugnara, et al.. (2012). Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors. Urology. 79(3). 644–649. 42 indexed citations

11.

Ferro, Antonella, Claudio Eccher, A. Caldara, et al.. (2012). Invasive lobular (ILC) versus invasive ductal (IDC) breast cancer (BC): Clinical-pathologic features and clinical outcomes in monoinstitutional series.. Journal of Clinical Oncology. 30(15_suppl). e21102–e21102.

12.

Barbareschi, Mattia, Salvatore Girlando, Emma Bragantini, et al.. (2012). PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(2). 129–139. 24 indexed citations

13.

Mustacchi, Giorgio, Annamaria Molino, Elena Fiorio, et al.. (2012). Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting.. Journal of Clinical Oncology. 30(15_suppl). 586–586. 2 indexed citations

14.

Murgia, Viviana, Roberto Sorio, C. Griso, et al.. (2010). Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer. International Journal of Gynecological Cancer. 20(6). 953–957. 4 indexed citations

15.

Bonomi, Maria, Rolando Nortilli, Teodoro Sava, et al.. (2009). Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. Medical Oncology. 27(2). 224–229. 21 indexed citations

16.

Murgia, Viviana, C Arcuri, Valentina Vanoni, et al.. (2009). 8039 Weekly cisplatin (wCDDP) with concurrent radiotherapy (cRT) in locally advanced cervical cancer (LACC) patients (pts): a monoinstitutional experience. European Journal of Cancer Supplements. 7(2). 461–461. 2 indexed citations

17.

Murgia, Viviana, Orazio Caffo, Roberto Sorio, et al.. (2008). Gemcitabine (G) and epirubicin (E) combination, in platinum-resistant or refractory advanced ovarian cancer (PROC) patients: Results of a multicentric phase II trial. Journal of Clinical Oncology. 26(15_suppl). 5566–5566.

18.

Graiff, Claudio, et al.. (2008). Systemic therapies for recurrent and/or metastatic salivary gland cancers. Expert Review of Anticancer Therapy. 8(3). 393–402. 27 indexed citations

19.

Molino, Annamaria, Monica Giovannini, A. Auriemma, et al.. (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Critical Reviews in Oncology/Hematology. 59(3). 226–233. 49 indexed citations

20.

Høegholm, Asbjørn, et al.. (1989). Benzodiazepine antagonism by aminophylline. Acta Anaesthesiologica Scandinavica. 33(2). 164–166. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact